Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.2250
-0.0050 (-2.17%)
Oct 9, 2026, 12:47 PM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 10.03 million as of October 9, 2026. It is the 43,505th most valuable company in the world and the 1,629th biggest in Canada. Its market cap has increased by 63.58% in one year.
Market Cap
10.03M
Enterprise Value
13.49M
Revenue
n/a
Global Rank
Country Rank
#1,629 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 10.03M, a decrease of -32.56%. That is a compound annual growth rate of -6.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 10.03M | 374.38% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 20.86M |
| Alzai Health | 20.09M |
| Lobe Sciences | 16.98M |
| Hemostemix | 13.74M |
| PreveCeutical Medical | 12.76M |
| Rapid Dose Therapeutics | 12.40M |
| Britannia Life Sciences | 10.70M |
| COSCIENS Biopharma | 9.15M |